Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Pointing Fingers On Biosimilars: FDA Versus FTC
01 Aug 2018
•
By
Michael McCaughan
US FDA is talking tough on antitrust enforcement. But is there any reason to think FTC is listening?
More from Biosimilars
More from Biosimilars & Generics